Vice President for Research

NIH Administrative Supplements to Support Cancer Disparity Collaborative Research
(Clinical Trial Optional)
Amount: $150,000 direct costs
Deadlines: September 06, 2022; January 23, 2023
The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups. Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets. Importantly, the supplemental request is required to be within the scope of the parent award and should expand the original aims to include a cancer disparity component and possible inclusion of international comparator cohorts.

NIH Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)=
Amount: According to scope
Deadlines: September 7, 2022 (AIDS Applications); May 17, 2023
The purpose of this funding opportunity announcement (FOA) is to support research on interventions to improve health in Native American (NA) populations. This includes 1) etiologic research, where there is a significant gap in knowledge, that will clearly inform intervention development or adaptation, 2) research that develops, adapts, and tests the efficacy or effectiveness of health promotion and disease prevention interventions, 3) research that tests culturally informed treatment or recovery interventions and 4) where a sufficient body of knowledge exists, research on dissemination and implementation that develops and tests strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions.

NIH NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators
to Promote Workforce Diversity (R01 Clinical Trial Optional)
Amount: According to scope, but see below

• NINDS intends to commit up to $10 million per fiscal year, approximately 25 awards,
  dependent on award amounts
• NIDA intends to commit up to $5 million per fiscal year, 12-15 awards, dependent on
  award amounts
• NIMH intends to commit up to $5 million per fiscal year, 12-15 awards, dependent on
  award amounts

Deadlines: September 8, 2022; January 6, 2023; May 5, 2023
This Funding Opportunity Announcement (FOA) solicits R01 grant applications that propose independent research projects that are within the scientific mission areas of the
participating NIH Institutes or Centers. This program is intended to support New Investigators and At-Risk Investigators from diverse backgrounds, including those from groups underrepresented in the health-related sciences. Investigators from diverse backgrounds, including those from underrepresented groups (e.g., see NOT-OD-20-031, Notice of NIH’s Interest in Diversity), are encouraged to work with their institutions to apply for support under this program. Investigators from categories A and B are particularly encouraged to work with their institutions to apply.

NIH Pragmatic Clinical Trials in Community Settings to Decrease or Prevent VCID Outcomes,
Including in Populations that Experience Health Disparities (U01 Clinical Trial Required)
Amount: according to scope
Deadline: September 15, 2022
The purpose of this funding opportunity announcement (FOA) is to solicit applications for pragmatic clinical trials to decrease or prevent negative clinical outcomes due to vascular contributions to cognitive impairment and dementia (VCID), including locally representative NIH defined populations that experience health disparities in dementia. Examples of responsive projects and interventions that affect VCID outcomes include, but are not limited to, blood pressure control implementation; lifestyle modification using aerobic exercise; and early detection and treatment of VCID risk factors.

NIH National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate
Research Training Program (T34)
Amount: According to scope
Deadline: September 26, 2022
The goal of the Bridges to the Baccalaureate Research Training Program is to provide structured activities to prepare a diverse cohort of research-oriented students to transfer from associate degree-granting institutions to baccalaureate degree-granting institutions and complete a baccalaureate degree in disciplines related to the biomedical sciences. This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-informed approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring, and career development elements. This program requires strong partnerships between at least two post-secondary educational institutions offering science, technology, engineering, or mathematics (STEM) degrees. At least one partner must be an institution that offers the associate degree as the highest STEM degree and the other partner(s) must offer baccalaureate degrees in biomedically relevant STEM fields. Upon completion of the Bridges to the Baccalaureate Research Training program, trainees are expected to be well positioned to pursue research-oriented biomedical higher degree programs or enter careers in the biomedical research workforce.

NIH AD/ADRD, Adverse Childhood Experiences, and Social Determinants of Health Ancillary
Studies of Existing Longitudinal Cohorts (R01 - Clinical Trial Not Allowed)
Amount: NINDS has committed $1,000,000 to fund up to two awards
Deadline: October 5, 2022
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that expand the use of existing data resources to drive new discoveries that can lead to better understanding of the relationship between early life social determinants of health (SDOH), adverse childhood experiences (ACEs), AD/ADRD biomarkers, and the development of cognitive impairment and dementia, especially in populations experiencing health disparities.

NIH Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices
in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved
Populations (R01 Clinical Trial Optional)
Amount: NIMH intends to commit $2,000,000 in FY 2022 to fund 3-4 awards.
Deadline: October 5, 2022; February 5, 2023; June 5, 2023 (Standard Dates)
This Funding Opportunity Announcement (FOA) encourages studies that develop and test the effectiveness of strategies for implementation and sustainable delivery of evidence-based mental health treatments and services to improve mental health outcomes for underserved populations in low-resourced settings in the United States. Studies should identify and use innovative approaches to remediate barriers to provision, receipt, and/or benefit from evidence-based practices (EBPs) and generate new information about factors integral to achieving equity in mental health outcomes for underserved populations. Research generating new information about factors causing/reducing disparities are strongly encouraged, including due consideration of the needs of individuals across the life span. This FOA is published in parallel to a companion R34, PAR-21-283,  that supports pilot studies in preparation for the larger-scale studies described here.

NIH New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and
Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)
Amount: Application budgets are not limited but must reflect the actual needs of the
proposed project (see RFA for commitments from NIH components).
Deadline: October 13, 2022
This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, invites applications for a Coordinating Center (CC) to establish a new population-based cohort study to address key population research gaps in the health of Asian Americans (AsA), Native Hawaiians, and Pacific Islanders (NHPI). This epidemiological cohort study will enable the enrollment, initial examination, and follow-up activities of a cohort of approximately 10,000 participants from multiple immigrant generations of ancestral Asian subpopulations, as well as Native Hawaiians and Pacific Islander subpopulations. Specifically, this initiative will utilize a “populomics” perspective, i.e., examination of health influences across multiple levels (biological, lifestyle/behavioral, environmental, sociocultural) using multi-disciplinary methods to investigate the web of influences impacting the health of AsA-NHPI subpopulations. This U24 cooperative agreement is administered by the National Heart, Lung, and Blood Institute (NHLBI), but includes extensive participation and funding contributions from a coalition of institutes at the National Institutes of Health (NIH). This FOA aims to systematically investigate factors of risk and resilience and potential mediators impacting the health of AsA-NHPI subpopulations in parallel with a companion FOA (RFA-HL-23-015) that encourages applications for Clinical or Community Field Centers (CCFCs).

NIH New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and
Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical
Trial Not Allowed)
Amount: The budget for each application may not exceed direct costs of up to $373,000 in Fiscal
Year (FY) 2023, up to $390,000 in FY2024, up to $406,000 per year in FYs 2025 through
2027, and up to $341,000 per year in FY2028 and FY2029.
Deadline: October 13, 2022
This Funding Opportunity Announcement (FOA) invites applications for Clinical or Community Field Centers (CCFC) to establish a new population-based cohort study to address key population research gaps in the health of Asian Americans (AsA), Native Hawaiians, and Pacific Islanders (NHPI). This epidemiological cohort study will enable the enrollment, initial examination, and follow-up activities of a cohort of approximately 10,000 participants from multiple immigrant generations of ancestral Asian subpopulations, as well as, Native Hawaiians, and Pacific Islander subpopulations. Specifically, this initiative will utilize a “populomics” perspective, i.e., examination of health influences across multiple levels (biological, lifestyle/behavioral, environmental, sociocultural) using multi-disciplinary methods to investigate the web of influences impacting the health of AsA-NHPI subpopulations. This FOA uses the bi-phasic, milestone-driven cooperative agreement mechanism (UG3/UH3) and runs in parallel with a companion FOA (RFA-HL-23-016) that encourages applications for a Coordinating Center (CC).

NIH Social Disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
Amount: $275,000 total direct costs
Deadline: October 15, 2022
The purpose of this FOA is to stimulate research to understand the link between social disconnection – including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) – and suicidal thoughts and behaviors in late-life. For the purposes of this FOA, social disconnection can be characterized by structural components (e.g., objectively few social relationships or infrequent social contact, whether driven by individual choice or societal forces), functional components (e.g., low or insufficient levels of social support and feelings of being excluded), and qualitative components (e.g., perceptions that relationships are of poor quality or are dissatisfying). Of specific interest is research that identifies mechanisms by which social disconnection confers risk for, and social integration protects against, suicidal thoughts and behaviors in late life. Research is encouraged
that addresses issues of health equity and health disparities in late life social connection and suicide, particularly work that adopts the NIA Health Disparities Research Framework. Research is also encouraged that adopts an intersectionality framework (i.e., a framework that addresses the multiple dimensions of individuals’ identity and social systems as they intersect with one another).

NIH Small Grants for New Investigators to Promote Diversity in Health-Related Research
(R21 Clinical Trial Optional)
Amount: $125,000 direct costs per year (max 3 years)
Deadline: October 16, 2022
The purpose of this Funding Opportunity Announcement (FOA) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical, clinical, behavioral and social sciences research, to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) , the National Human Genome Research Institute (NHGRI) or the National Institute of Biomedical Imaging and Bioengineering (NIBIB). New investigators at the time of award under this FOA will have had less than $125,000 direct costs of combined research funding (excluding NIH training and NIH career awards). This R21 will support small research projects that can be carried out in a short period of time with limited resources and seeks to facilitate transition to research independence. The R21 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

NIH Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource
Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required )
Amount: $225,000 direct costs per year and $450,000 over the 3-year project period
Deadline: October 16, 2022; February 16, 2023; June 16, 2023 (Standard Dates)
This Funding Opportunity Announcement (FOA) supports pilot work for subsequent  studies testing the effectiveness of strategies to deliver evidence-based mental health services, treatment interventions, and/or preventive interventions (EBPs) in low-resourced mental health specialty and non-specialty settings within the United States. The FOA targets settings where EBPs are not currently delivered or delivered with fidelity, such that there are disparities in mental health and related functional outcomes (e.g., employment, educational attainment, stable housing, integration in the community, treatment of comorbid substance use disorders) for the population(s) served. Implementation strategies should identify and use innovative approaches to remediate barriers to provision, receipt, and/or benefit from EBPs and generate new information about factors integral to achieving equity in mental health outcomes for underserved populations. Research generating new information about factors causing/reducing disparities is strongly encouraged, including due consideration for the needs of individuals across the life span. Applications proposing definitive tests of an implementation strategy should respond to the companion R01 announcement PAR-21-284.

NIH Building Infrastructure for Precision Medicine Research on Minority Health and
Disparities in Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (UH2/UH3 Clinical
Trial Not Allowed)
Amount: NIA intends to commit $2.8 million in fiscal year 2023 to fund five awards
Deadline: October 21, 2022
This funding opportunity (FOA) promotes collaborative research programs to support  the development of research infrastructure (e.g., tools, surveys, biospecimens, data, etc.) for precision medicine approaches for minority health and health disparities in Alzheimer's disease (AD) and AD-related dementias (ADRD). This FOA serves as a
catalytic opportunity for investigators to: (1) focus on populations understudied in AD/ADRD research; (2) build resources that include neurobiological, environmental, behavioral, and social science data; and (3) initiate innovative, integrated, an expanded studies of individuals from these populations. Specifically, the National Institute on Aging (NIA) seeks to support Phase Innovation Awards Cooperative Agreement (UH2/UH3) projects to enable: (1) the formation of transformative, multi-disciplinary teams to address disparities in health outcomes, disease burden, and/or resilience among understudied populations with AD/ADRD; (2) the development, or scaling up, of research infrastructure and resources for studies of AD/ADRD in understudied populations; and (3) pilot projects that incorporate multi-level assessments and approaches to elucidate intersecting behavioral, social, environmental, neural, and physiological pathways affecting or mitigating AD/ADRD outcomes in these populations.

NIH Expanding Prevention Strategies for Mental Disorders in Mobile Populations in
Humanitarian Crises (R34 Clinical Trial Optional)
Amount: $450,000 direct costs
Deadline: October 25, 2022
The National Institute of Mental Health is issuing this Funding Opportunity Announcement (FOA) and seeks to fund research focused on understanding the role human mobility has on mental health outcomes and developing and testing culturally appropriate preventive interventions for mental disorders that may develop during all phases of migration.
This FOA seeks to develop assessment tools, preventive interventions, and implementation approaches to improve mental health outcomes in mobile populations. Applications of
interest include those that refine and test scalable and sustainable approaches for intervention use during humanitarian crises. Per UNICEF a humanitarian crisis is defined as "any circumstance where humanitarian needs are sufficiently large and complex to require significant external assistance and resources, and where a multi-sectoral response is needed, with the engagement of a wide range of international humanitarian actors (IASC)." NIMH encourages research that addresses the mental health care needs of mobile children, adolescents, youth, women, people with serious mental illness, sexual and gender minorities, people with disabilities, older adults, and separated families.

Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes
Research (U2C - Clinical Trial Not Allowed)
Amount: $1,900,000 direct costs per year up to five years
Deadline: October 26, 2022
This U2C Funding Opportunity Announcement (FOA) is a National Institute of Diabetes  and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 2 diabetes research (SEIC-T2D). A primary goal of the SEIC-T2D is to accelerate equitable engagement of individuals from and communities of diverse backgrounds and sectors in developing the research priorities and activities that involve them, particularly underserved communities, and those with the highest proportion of diabetes-related morbidity and mortality. The SEIC-T2D will provide highly specialized research resources to support field investigators by fully embedding communities, patients, and other stakeholders into the full spectrum of research activities through expert consultations and education in principles and methods of community-engaged research. The SEIC-T2D will also establish a network consisting of multidisciplinary research investigators, including from underrepresented groups, with expertise in T2D and community-engaged methods, community experts with lived experiences, and representatives of various health and other organizations deemed essential for addressing disparities and advancing health equity in T2D prevention and treatment.

NIH Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER)
Research Education R25 (R25 Clinical Trial Not Allowed)
Amount: $150,000 in direct costs per year
Deadline: October 27, 2022 | AIDS Application Deadline: January 7, 2023
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The overarching goal of this ORWH R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s diverse biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development and Curriculum or Methods Development. Courses supported by this FOA should develop, implement, evaluate, and disseminate education and training to advance health-related research on sex (as a biological variable); gender (as a social determinant of health); and/or the consideration of interactions between sex and gender. Courses that take an intersectional approach to explore how sex and gender interact with other identity categories (e.g., race, ethnicity, sexual orientation, and others) to create disparate outcomes for certain individuals, groups, and communities, are strongly encouraged.  Although courses can focus on a specific application (e.g., trauma informed care) or methodology (e.g. intersectional health research), applicants should also consider how that specific application can be of relevance to sex and gender research broadly. Curricula and methods development activities supported by this FOA should advance understanding of sex and/or gender influences on health, for example, intersectional methods and approaches for studying sex and/or gender. Activities can integrate knowledge of sex and gender influences into existing trainings or develop novel methods or curricula. Supported curricula will be made freely available, at no cost to the broader community, through the ORWH website; programs must be self-sustaining at the end of the award period.

NIH Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control,
U54 Clinical Trial Optional)
Amount: Up to $750,000 per year in direct costs
Deadline: November 8, 2022
The purpose of the Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control) Funding Opportunity Announcement (FOA) is to build implementation science centers in low- and middle-income countries (LMICs). This initiative will support implementation science research capacity-building activities, including research projects that identify, develop, and test innovative theory-based strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based cancer control interventions (e.g., programs, tools, policies, and guidelines) in LMICs. NCI will support several U54 Specialized Centers with transdisciplinary research teams meaningfully collaborating with key stakeholders (e.g., health systems, ministries of health, clinicians, and communities) that must include at least one PI or MPI from an LMIC-based institution. This initiative aims to foster LMIC-based implementation science programs to inform implementation of cancer control efforts in LMICs.

NIH NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through
Community-Engaged Research (R01 Clinical Trial Optional)
Amount: NIDA intends to commit approximately $2 million total in FY 2023 for this
initiative, spread across RFA-DA-23-013 and RFA-DA-23-032.
Deadline: November 14, 2022
This Funding Opportunity Announcement (FOA) is a part of NIDA’s Racial Equity Initiative (REI). This FOA invites R01 applications to conduct research that will have a major
impact in identifying, developing, implementing, or testing strategies to improve outcomes related to substance misuse, with a goal of preventing, reducing, or eliminating disparities in racial and/or ethnic communities in substance use, addiction, and related health consequences, including HIV. Community engaged research can facilitate rapid advances in this scientific area by ensuring relevant research questions with immediate applicability. As such, applications must be submitted by collaborative community partnered investigative teams who will conduct research projects that address issues prioritized by the relevant communities. No preliminary data are required. However, projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce desired outcomes.

NIH NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel
Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic
Populations (R01 Clinical Trial Optional)
Amount: NIDA intends to commit $3,000,000 in FY 2023 to fund 5-9 awards between this
FOA and the companion FOA RFA-DA-23-024.
Deadline: November 14, 2022
This Funding Opportunity Announcement (FOA) is a part of NIDA’s Racial Equity Initiative (REI), with goals that include promoting racial equity in NIDA’s research portfolio. The purpose of this FOA is to stimulate new observational and intervention research on structural factors, organizational practices, policies, and other social, cultural, and contextual influences that lead to inequities at the intersection of HIV and substance use among underserved racial and/or ethnic minority populations affected by persistent HIV disparities. Research that addresses the multiple dimensions of individuals’ identity (e.g., race, ethnicity, gender, sexual orientation, gender identity) and social systems as they intersect with one another is encouraged.

NIH NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel
Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic
Populations (R34 Clinical Trial Optional)
Amount: NIDA intends to commit $3,000,000 in FY 2023 to fund 5-9 awards between this FOA and
the companion FOA RFA-DA-23-023.
Deadline: November 14, 2022
This Funding Opportunity Announcement (FOA) is a part of NIDA’s Racial Equity Initiative (REI), with goals that include promoting racial equity in NIDA’s research portfolio. The purpose of this FOA is to support pilot or feasibility research on structural factors, organizational practices, policies, and other social, cultural, and contextual influences that lead to inequities at the intersection of HIV and substance use among underserved racial and/or ethnic minority populations affected by persistent HIV disparities. Research that addresses the multiple dimensions of individuals’ identity (e.g., race, ethnicity, gender, sexual orientation, gender identity) and social systems as they intersect with one another is encouraged.

NIH NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use
and Racial Equity (DP1 Clinical Trial Optional)
Amount: NIDA intends to commit approximately $2,000,000 to fund 2-3 awards each year between
this FOA and the companion FOA, RFA-DA-23-031.
Deadline: November 14, 2022
This Funding Opportunity Announcement (FOA) is a part of NIDA’s Racial Equity Initiative (REI), with goals that include promoting racial equity in NIDA’s research portfolio.. This announcement invites applications supporting independent, early career or established scholars who self-identify as health equity, health disparities, or social determinants of health experts with the skills to make exceptionally creative contributions to the study of equity for underserved U.S. racial and/or ethnic minority groups that experience poorer outcomes related to substance use and substance use disorders. This award supports transformative, boundary-pushing applications that may be risky or at a stage too early to fare well in the traditional peer review process.

NIH NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural
Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
Amount: NIDA intends to commit $1.5 million in FY 23, 24, and 25 for this and the companion
funding announcement (RFA-DA-23-029, for which applicant institutions must be a Minority Serving Institution) to fund
3-5 awards yearly.
Deadline: November 14, 2022
This Funding Opportunity Announcement (FOA) is a part of NIDA’s Racial Equity Initiative (REI) and invites clinical research applications that are exploratory/developmental in nature and seek to parse the complex effects of structural racism and investigate their impact on neurocognition, with an emphasis on reducing SUD risk and informing preventative interventions.

NIH NIDA REI: Coordination Center to Support Racial Equity and Substance Use Disparities
Research (U24 Clinical Trial Not Allowed)
Amount: NIDA intends to commit up to $750,000 in FY 2023 to fund 1 award.
Deadline: November 15, 2022
The National Institute on Drug Abuse (NIDA) seeks applications for a Coordination Center to create synergy and linkages across projects funded under NIDA's Racial Equity Initiative (REI) funding opportunity annoucements. The Center will provide coordination for collaborative products and activities while housing shared resources. In addition, the Center will optimize the impact of individual REI projects by strengthening community-engaged research efforts and supporting the dissemination and usage of research products and innovations.

NIH Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health
Equity (U2C Clinical Trial Not Allowed)
Amount: NIDDK intends to commit $2,500,000 in Fiscal Year 2023 to fund one award
Deadline: November 17, 2022
This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 1 diabetes research (SEIC-T1D). A primary goal of the SEIC-T1D is to accelerate equitable engagement of diverse stakeholders (specifically people from NIH designated health disparities populations) in T1D research; particularly those from communities that experience diabetes-related health disparities and live within the healthcare and social systems that negatively impact community members’ and patients’ health. The SEIC-T1D will provide highly specialized research resources to support investigators by fully embedding communities, people living with T1D, and other stakeholders into the full spectrum of research activities through expert consultations and education in principles and methods of community-engaged research. The SEIC-T1D will also establish a network consisting of diverse, multidisciplinary
research investigators with expertise in T1D and community-engaged methods, community experts with lived experiences, and representatives of various health and other organizations deemed essential for addressing disparities and advancing health equity in T1D early detection and treatment.

NIH Interventions that Address Structural Racism to Reduce Kidney Health Disparities
- (U01 - Clinical Trial Required)
Amount: $500,000 direct costs per year
Deadline: November 17, 2022
The Interventions that Address Structural Racism to Reduce Kidney Health Disparities Consortium aims to foster community-engaged intervention research to address structural racism to reduce health disparities among individuals living with kidney disease. This Funding Opportunity Announcement (FOA) invites applications for Intervention Sites that will work collaboratively with a Research Coordinating Center (RCC) (see RFA-DK-22-015) to develop and test meaningful interventions that aim to dismantle or mitigate the effects of structural racism to reduce kidney health disparities. Studies proposed by the successful applicants may be substantially revised prior to being undertaken by the Consortium, including the potential of harmonizing intervention components and data collection measures across Intervention Sites.

NIH Interventions that Address Structural Racism to Reduce Kidney Health Disparities
– Research Coordinating Center (U24 - Clinical Trial Not Allowed)
Amount: $500,000 direct costs per year (excluding opportunity pool).  Applicants may ask for
$100,000 or more per year for the opportunity pool.
Deadline: November 17, 2022
The Interventions that Address Structural Racism to Reduce Kidney Health Disparities Consortium aims to foster community-engaged intervention research to address structural racism to reduce health disparities among individuals living with kidney disease. The Consortium will consist of one Research Coordinating Center and multiple Intervention Sites (see RFA-DK-22-014) that will work collaboratively to develop, implement and evaluate meaningful interventions that aim to dismantle or mitigate the effects of structural racism to reduce kidney health disparities. This Funding Opportunity Announcement (FOA) invites applications for the Research Coordinating Center (RCC) that will lead, manage, and harmonize efforts for the Consortium. The specific activities of the RCC will include: 1) providing organization, management, and administrative support of Consortium activities; 2) providing research coordination, data management and data analyses for Consortium studies; and 3) fostering research collaborations and helping to build a community of investigators with skills to develop, implement, and disseminate effective, scalable, and sustainable interventions that address the structural drivers of kidney health disparities.